Certified by Founder
Lodge
hema.to GmbH
start up
Germany
- Munich
- 07/03/2025
- Unknown
- $3,900,060
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
- Industry Software Development
- Website https://www.hema.to/
- LinkedIn https://www.linkedin.com/company/hemato/
Related People
Karsten MiermansFounder
Germany -
Munich, Bavaria
Founder of an AI diagnostic start-up, passionate about improving cytometry and blood cancer diagnostics. I have a background in theoretical biophysics, but I'm a generalist at heart. My fundamental drivers are growth, honesty, efficiency and curiosity. In my spare time, I enjoy reading great works, electronic music and teaching rationality.
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)